30 July 2018 – Alphabet Shares Hit All-time High

With Facebook and Netflix stumbling without recognised corporate venturing units, it has been interesting to see the other big four US internet companies, Microsoft, Amazon, Alphabet and Apple, with powerful CVC investments report or predict strong results.

Alphabet was the most clear-cut as it reported better-than-expected second-quarter earnings last Monday, driving Alphabet shares to a new all-time high the following day. It generated adjusted earnings per share of $11.75 versus the Wall Street consensus of $9.59 for the quarter, according to cable news provider CNBC. Alphabet also posted a $1.06bn gain in its equity investments for the time period, which translated into $1.17 EPS of the outperformance.

Funds

With the growth of investment in the VC space, it’s often not just the hard transactions that raise an eyebrow but also prospective deals, and so it is today. Rocket Internet has built up a mass of e-commerce holdings by focusing on Europe and the emerging markets, but is reportedly now eyeing the US and raising between $1bn and $2bn for a corporate venturing fund that will focus on that region.

Credit Suisse Next Investors closes $261m fund

BIF’s fundraising efforts beget $50m

University

UNC Chapel Hill details incubator proposal

Deals

New TV, the short-form video producer formed by entertainment vet Jeffrey Katzenberg and overseen by his WndrCo company, has closed $1bn in funding, $200m of which was supplied by large entertainment companies such as Disney, Warner Bros, 21st Century Fox and Entertainment One.

Elsewhere in China, facial recognition software provider Megvii has raised upwards of $600m from investors including Alibaba and will use the cash to spearhead an expansion of its technology in the retail space.

WeWork launched its WeWork China offshoot a year ago with $500m in series A funding, and WeWork China has now doubled that, raising another $500m in a series B round co-led by five investors including both SoftBank and SoftBank Vision Fund.

Tencent is reportedly lining up an investment of $300m to $500m in India-based short-term accommodation provider Oyo Rooms that will support the latter’s expansion in China, a market now responsible for almost all its overseas revenue.

Genetic testing services and research provider 23andme was valued at $1.75bn last September when it last raised funding, but that valuation is surely higher now it’s closed a $300m investment by GlaxoSmithKline in connection with a collaboration agreement.

Alector collects $133m in series E funding

The RealReal luxuriates in $115m

Stem grows bigger to close $106m round

Cancer radiotherapy technology and services provider Allcure was spun off with the telemedicine assets of hospital management services provider Concord Medical Services in 2015, and three years later the company has raised a reported $103m in series B funding.

University

Galvanize animates $32m series C

Beddr snuggles up to $5.6m series A

Exits

Group buying platform Pinduoduo has become the latest Chinese tech company to go public in the US, floating at the top of its range to raise $1.6bn, just three years after it was founded.

Pinterest meanwhile is looking to launch an initial public offering in a year’s time in order to capitalise on a boost to its advertising stream that is set to double ad revenue to $1bn in 2018.

Huya had a fairly successful IPO in the US a few months back and now its chief rival in China’s livestreaming space, Douyu, is looking to follow the same path, preparing for an offering expected to net it between $600m and $700m.

Ascletis has priced a $400m initial public offering in Hong Kong in the middle of its range, a month after its lead hepatits C treatment received regulatory approval in China.

It’s been a long wait for fuel cell system supplier Bloom Energy, which was founded in 2001 and first touted for an IPO at the latter end of that decade.

Allakos, which is developing antibodies to treat white blood cell-related conditions, has had one of the year’s more successful IPOs, pricing its shares above the range to raise $128m, before watching its stock almost double in price in the first two days of trading.

Constellation consummates $60m IPO

Aridis arrows to public markets

LevelUp rewards investors with $390m exit

Stamps.com collects MetaPack in $230m deal


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

02 July 2018 – AT&T Agrees Acquisition of AppNexus

Exits

AT&T has agreed an acquisition of AppNexus reported to be priced around the $1.6bn mark, enabling WPP, Microsoft, News Corp and Deutsche Telekom to exit.

PayPal sinks $120m into Simility acquisition

University

TTTech sells stake to B&C

Xiaomi’s IPO has been a long, hard slog for the company. It had originally aimed to raise $10bn in a dual Hong Kong and Shanghai listing that would have valued it at about $100bn, but the Qualcomm-backed electronics producer has had to settle for a $4.7bn offering, solely in Hong Kong, which valued it at $54bn.

Chinese automotive e-commerce marketplace Cango has filed to raise up to $300m in a US-based initial public offering that will allow Tencent, Didi Chuxing and Taikang Life Insurance to exit.

A more recently thriving space involves livestreaming, and China-based Inke has set the terms for an initial public offering in Hong Kong that will net $167m if it floats at the top of the range.

Babytree, a China-based online platform that combines baby and child products, development advice and social networking for parents, has filed for an IPO in its home country.

Outside of China, life sciences companies are driving the US IPO surge, much as they did three three or four years ago. Some half dozen healthcare companies floated the previous week including Magenta Therapeutics, which secured $100m when it floated.

Cancer drug developer Constellation Pharmaceuticals has filed to raise up to $86.3m in an offering that will follow almost $230m in equity funding.

Translate Bio, a developer of messenger RNA drugs for diseases caused by gene or protein dysfunction, has raised over $121m in its own IPO, in the US.

Neon shows way to $100m IPO

Kezar kicks into public markets

Xeris reformulates path to IPO

ElectroCore enters public markets with $78m offering

Allakos aligns itself with $75m IPO

Deals

Transport services provider Go-Jek closed a $1.5bn round earlier this year at a $4.8bn valuation, and is now in talks to raise the same amount in a new round, according to The Information.

Evergrande Health Industry, part of property developer China Evergrande, has taken a 45% stake in smart electric vehicle developer Faraday Future, paying $860m for Season Smart, the investment entity that held a 45% stake in the company.

Showing once again that ride hailing continues to be a vibrant destination for venture funding, Lyft has raised $600m in a Fidelity-led round that valued it at more than $15bn post-money.

PolicyBazaar signs up SoftBank for $238m round

Helix has closed a series B round backed by Illumina and Mayo Clinic at $200m, and will use the funding to expand its personal genomics product marketplace.

Precision BioSciences has closed a $110m series B round backed by Amgen Ventures, Brace Pharma Capital and Alexandria Venture Investments, and will use the proceeds to expand the portfolio of products centred on its genome editing platform.

Advanced battery developer QuantumScape has largely operated in stealth since it was founded in 2010 but has received $100m from Volkswagen as part of a deal that will involve the companies forming a joint venture to bring solid-state batteries to the industrial-scale manufacturing stage by 2025.

AISpeech aces latest round

Cibus harvests $70m in series C funding

B-Stock beats its way to $65m

TouchBistro completes $54m series D order

Carisma charms investors in $53m series A

AIpark finds space for Nio in series B

University

Pennsylvania lines up $50m

Irish spinout generation slides in 2017

Funds

Dementia Discovery Fund delivers $350m close

Charles University spawns TTO


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0